Filter posts

#BIOCEO16 Fireside Chat with Senator Chuck Schumer

New York Senator Chuck Schumer joined attendees at the 2016 BIO CEO & Investor Conference …

Tomorrow: From Volume to Value: Designing a Patient-Centered Healthcare System (Webcast)

Tomorrow at the Newseum, The Hill will be hosting a live discussion about the transition …

Know Your IP Strategy: A Necessity for Technology Start-ups

The Licensing Executives Society Foundation invites start-up companies, with investments of less than $200,000, and …

Patently Biotech’s Top Articles of 2015

Intellectual property and patent reform have dominated headlines in 2015. As we close out the …

Patent Reform in the News

The New York Post and The Washington Post have both run Op-eds in the last week addressing …

A National Blueprint for Biodefense Released Today

A major report was released today detailing findings and recommendations to improve the U.S. biodefense …

Biotech Policy Outlook at #BIF15: 21st Century Cures, IPR, TPP, and PDUFA VI

To even the most casual observer, 2015 has been a big year in the biotech …

PTAB Ruling Proves Medical Innovation Under Attack

There’s more evidence today that the IPR system needs to be fixed. PTAB ruled on …

BIO on CNBC: IPR System Weakens Medical Innovation

Last night Ron Cohen, M.D., CEO of Acorda Therapeutics and BIO’s board chair, appeared on …

Here are the Facts about the IPR Kill Rate

FiercePhrma recently ran an article repeating a dubious analysis of the crisis caused by the …